PNC Financial Services Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-100,000
| Closed | -$410K | – | 4860 |
|
|
2022
Q1 | $410K | Hold |
100,000
| – | – | ﹤0.01% | 1804 |
|
|
2021
Q4 | $357K | Hold |
100,000
| – | – | ﹤0.01% | 1907 |
|
|
2021
Q3 | $364K | Hold |
100,000
| – | – | ﹤0.01% | 1815 |
|
|
2021
Q2 | $436K | Hold |
100,000
| – | – | ﹤0.01% | 1695 |
|
|
2021
Q1 | $411K | Hold |
100,000
| – | – | ﹤0.01% | 1703 |
|
|
2020
Q4 | $399K | Hold |
100,000
| – | – | ﹤0.01% | 1633 |
|
|
2020
Q3 | $270K | Hold |
100,000
| – | – | ﹤0.01% | 1753 |
|
|
2020
Q2 | $275K | Hold |
100,000
| – | – | ﹤0.01% | 1744 |
|
|
2020
Q1 | $236K | Sell |
100,000
-262
| -0.3% | -$891 | ﹤0.01% | 1723 |
|
|
2019
Q4 | $471K | Sell |
100,262
-26,824
| -21% | -$110K | ﹤0.01% | 1512 |
|
|
2019
Q3 | $426K | Sell |
127,086
-21,570
| -15% | -$71K | ﹤0.01% | 1677 |
|
|
2019
Q2 | $489K | Sell |
148,656
-9,938
| -6% | -$28.8K | ﹤0.01% | 1633 |
|
|
2019
Q1 | $481K | Sell |
158,594
-63,445
| -29% | -$206K | ﹤0.01% | 1659 |
|
|
2018
Q4 | $604K | Buy |
222,039
+122,039
| +122% | +$402K | ﹤0.01% | 1465 |
|
|
2018
Q3 | $336K | Hold |
100,000
| – | – | ﹤0.01% | 1895 |
|
|
2018
Q2 | $258K | Hold |
100,000
| – | – | ﹤0.01% | 2040 |
|
|
2018
Q1 | $220K | Hold |
100,000
| – | – | ﹤0.01% | 2115 |
|
|
2017
Q4 | $199K | Hold |
100,000
| – | – | ﹤0.01% | 2190 |
|
|
2017
Q3 | $324K | Hold |
100,000
| – | – | ﹤0.01% | 1870 |
|
|
2017
Q2 | $322K | Hold |
100,000
| – | – | ﹤0.01% | 1848 |
|
|
2017
Q1 | $284K | Hold |
100,000
| – | – | ﹤0.01% | 1938 |
|
|
2016
Q4 | $233K | Buy |
+100,000
| New | +$190K | ﹤0.01% | 2033 |
|
|
2016
Q3 | – | Sell |
-675
| Closed | -$1K | – | 4376 |
|
|
2016
Q2 | $1K | Sell |
675
-27
| -4% | -$26 | ﹤0.01% | 4413 |
|
|
2016
Q1 | $1K | Buy |
702
+24
| +4% | +$23 | ﹤0.01% | 4415 |
|
|
2015
Q4 | $1K | Sell |
678
-2,000
| -75% | -$2.78K | ﹤0.01% | 4377 |
|
|
2015
Q3 | $5K | Buy |
2,678
+23
| +0.9% | +$45 | ﹤0.01% | 3989 |
|
|
2015
Q2 | $5K | Buy |
2,655
+279
| +12% | +$677 | ﹤0.01% | 4096 |
|
|
2015
Q1 | $7K | Hold |
2,376
| – | – | ﹤0.01% | 3934 |
|
|
2014
Q4 | $7K | Sell |
2,376
-1,000
| -30% | -$2.25K | ﹤0.01% | 3466 |
|
|
2014
Q3 | $7K | Sell |
3,376
-17,200
| -84% | -$37.5K | ﹤0.01% | 3384 |
|
|
2014
Q2 | $56K | Hold |
20,576
| – | – | ﹤0.01% | 2532 |
|
|
2014
Q1 | $73K | Sell |
20,576
-7,624
| -27% | -$33.8K | ﹤0.01% | 2352 |
|
|
2013
Q4 | $126K | Buy |
28,200
+2,000
| +8% | +$8.15K | ﹤0.01% | 2072 |
|
|
2013
Q3 | $106K | Buy |
26,200
+11,200
| +75% | +$48.9K | ﹤0.01% | 2150 |
|
|
2013
Q2 | $62K | Buy |
+15,000
| New | +$57.9K | ﹤0.01% | 2303 |
|
Other funds holding ATRS
PNC Financial Services Group's ATRS Position: Q2 2022 in Review
PNC Financial Services Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 100,000 shares — an estimated $410K sold.
PNC Financial Services Group first reported a position in ATRS in Q2 2013 and held it in 35 quarters. The position peaked at $604K in Q4 2018. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- PNC Financial Services Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- PNC Financial Services Group sold 100,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $410K.
- PNC Financial Services Group first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 35 quarters.
- PNC Financial Services Group's Antares Pharma, Inc. position peaked at $604K in Q4 2018.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on PNC Financial Services Group's 13F filing for Q2 2022, filed 12 Aug 2022.